Gregory Sullivan Chief Medical Officer, Tonix Pharmaceuticals emphasized that the findings reinforce TONMYAs ability to deliver rapid pain relief with a favorable benefit-risk profile for patients living with fibromyalgia
However, that does not mean every peptide being marketed has been adequately studied. I dont think the question is whether peptides are good or bad
doi: 10.1177/003693307502000309
It also reduced muscle damage markers, implying improved recovery.29 Liver health In a study of subjects with nonalcoholic fatty liver disease, a 100mg dose of CoQ10 resulted in a significant reduction in markers associated with inflammation and tumor development over 12 weeks.10 A later study used a slightly higher 240mg dose in liver disease patients and found improvements in liver steatosis and endothelial, vascular, and left ventricular function.30 Skin quality In a relatively small-scale study of 33 participants, 150mg of CoQ10 successfully reduced wrinkles and other signs of aging, though it didnt seem to affect dermal hydration.11 Blood sugar control A meta-analysis of 40 studies found that 100-200mg of CoQ10 was sufficient to help control blood sugar, particularly among diabetics.12 A later umbrella review concluded similarly, stating that Supplementation with CoQ10 may be beneficial, especially in populations with diabetes mellitus or other endocrine and metabolic disorders
The FDA did not give the public a chance to weigh in on its decision and trusted assurances from Lilly, the company that is self-interested in monopolizing the market, that it could meet projected demand, the lawsuit said
